Full Text View
Tabular View
No Study Results Posted
Related Studies
Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
This study is currently recruiting participants.
Verified June 2010 by Taipei Veterans General Hospital,Taiwan
Study NCT01175486   Information provided by Taipei Veterans General Hospital,Taiwan

First Received on July 23, 2010.   Last Updated on January 4, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetic Retinopathy
Kidney Diseases
Retinal Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetic Angiopathies
Endocrine System Diseases
Eye Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
Actos (Pioglitazone)
Acarbose
Additional drug interventions recognized in this trial
2,4-thiazolidinedione
Pioglitazone
More general drug interventions related to this trial
Enzyme Inhibitors
Hypoglycemic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Taipei Veterans General Hospital,Taiwan


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services